LipAgg

Doctoral Network
on Amyloid Protein

LipAgg partners

The LipAgg project brings together a multidisciplinary and highly complementary consortium composed of leading academic institutions, innovative companies, and a patient association from across Europe.

LipAgg fosters a robust collaborative environment conducive to scientific advancements. The programme will provide an excellent training environment for 15 doctoral candidates, who will benefit from the complementary expertise of the partners, as well as from a strong network promoting the sharing of knowledge, methods, and dedicated training activities.

gottingen
biofordrug
bioartic
biosolveit
bruker
hhu
labbot
ludbeck
parkinson
Aminoverse
AMINOVERSE
universite-bordeaux
polypeptide
research-pieces
schrodinger
Plasseraud
Aminoverse B.V.

Netherlands

BIOARCTIC AB

Sweden

PROBATION LABS SWEDEN AB

Sweden

BIOFORDRUG SRL

Italy

BIOSOLVEIT GMBH

Germany

BRUKER BIOSPIN GMBH & CO KG

Germany

GEORG-AUGUST-UNIVERSITAT GOTTINGEN STIFTUNG OFFENTLICHEN RECHTS

Germany

HEINRICH-HEINE-UNIVERSITAET DUESSELDORF

Germany

H. LUNDBECK AS

Denmark

Parkinsonforeningen

Denmark

PLASSERAUD IP

France

Polypeptide Laboratories France SAS

France

Research PIECES

France

SCHRODINGER GMBH

Germany

UNIVERSITE DE BORDEAUX

France

Close

Guiding principles and recommendations

MSCA participants are expected to explain the actions they are taking to address the sustainability of their research projects in their proposals and at final reporting stage.

Sustainability can play a role as an additional criterion in the evaluation of ex-aequo proposals.

To help participants better understand how they can integrate sustainability concerns into projects in practice, the charter and its supporting material offer practical recommendations covering topics such as :

  • travel, events and meetings
  • resource-intensive research settings
  • hardware, software and data usage
  • facilities, infrastructure and procurement.

While the relevance of the charter’s principles and recommendations may vary depending on the MSCA participants and projects, the guidance documents are there to help everyone find the resources they need depending on their own situation.

Biography : Lucie Khemtemourian

I am a researcher at the Institute of Chemistry and Biology of Membranes and Nano-Objects (CBMN, CNRS, France).

I joined CNRS in 2009 after receiving my PhD in Physical Chemistry from the University of Bordeaux (France) and completing postdoctoral training at Université Paris Cité (France, UMR 8601) under the supervision of Prof. Dr. Isabelle Artaud and at Utrecht University under the supervision of Prof. Dr. J. Antoinette Killian (the Netherlands).

My current research focuses on the molecular mechanisms of amyloid-forming proteins and on the interactions between amyloid proteins and membranes, ranging from artificial membranes to cellular membranes. I am particularly interested in islet amyloid polypeptide, which is associated with type 2 diabetes.

I am the coordinator of the Horizon Europe Marie Skłodowska-Curie Actions Doctoral Network LipAgg project.